TABLE OF CONTENTS

Volume 13, Issue 1 (October 2006)

Top

Papers

Biotechnology in Cuba: 20 years of scientific, social and economic progress FREE

Ernesto López Mola, Ricardo Silva, Boris Acevedo, José A Buxadó, Angel Aguilera and Luis Herrera

J Commer Biotechnol 13: 1-11; doi:10.1057/palgrave.jcb.3050038

Country-of-origin effect of VC investment in biotechnology companies

Siah Hwee Ang

J Commer Biotechnol 13: 12-19; doi:10.1057/palgrave.jcb.3050035

A retrospective prospective perspective on agricultural biotechnology ten years on

Martina Newell McGloughlin

J Commer Biotechnol 13: 20-27; doi:10.1057/palgrave.jcb.3050031

Using intellectual property to map the organisational evolution of firms: Tracing a biotechnology company from startup to bureaucracy to a multidivisional firm

Iraj Daizadeh

J Commer Biotechnol 13: 28-36; doi:10.1057/palgrave.jcb.3050032

When is patent infringement not patent infringement? Merck v Integra and the 'safe harbour'

Karen I Boyd

J Commer Biotechnol 13: 37-42; doi:10.1057/palgrave.jcb.3050036

Media coverage and biotechnology IPOs: Some Australian evidence

Paul Jens, Robert Brooks, Gina Nicoletti and Roslyn Russell

J Commer Biotechnol 13: 43-47; doi:10.1057/palgrave.jcb.3050033

Top

Marketspace

Increased uptake of biologics in historically small molecule blockbuster-dominated therapeutic areas

Duncan A N Emerton and Mark J Belsey

J Commer Biotechnol 13: 48-51; doi:10.1057/palgrave.jcb.3050034

Legal and regulatory update

J Commer Biotechnol 13: 52-63; doi:10.1057/palgrave.jcb.3050030

Extra navigation

.
ADVERTISEMENT